edaravone
Active substance: edaravone
INJECTION, SOLUTION · EDARAVONE 60 mg/100mL
United StatesActive
Marketing holder: Gland Pharma Limited
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- EDARAVONE · 60 mg/100mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-7e87-7bfa-974b-eb3bc4c62d9b,01a1208d-8a2d-78e3-9d32-1f4d7361f7a3,01a1208d-8a32-7392-9f3e-97ab393d97aa,01a1208e-d847-7292-93be-4ca528bf50a9,01a12093-0ea3-79a5-9382-c53ce7d4ad1f;count=6 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 68083-501
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 68083-501 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 68083-501 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 68083-501 · Verified 2026-10-09 · open in source